By Choma Amajor
In a landmark diplomatic move, the High Commissioner of Bangladesh to Nigeria, His Excellency Mr. Miah Md. Kabir, visited the National Agency for Food and Drug Administration and Control (NAFDAC) headquarters in Abuja to propose a high-level partnership in pharmaceutical development and trade expansion.
The engagement with NAFDAC Director-General, Prof. Mojisola Christianah Adeyeye, marks a pivotal shift toward strengthening South-South cooperation, focusing on technology transfer and local manufacturing.
The Vision: From Importation to Local Production
The High Commissioner highlighted that Bangladesh, with its population of over 180 million and a sophisticated pharmaceutical export record, sees Nigeria as a vital strategic partner. The goal? To move beyond simple trade and into deep-rooted investment.
Why Nigeria is Ready for the Global Stage
Prof. Adeyeye outlined the massive strides Nigeria has made in regulatory excellence:
WHO Maturity Level 3: This elite status has transformed Nigeria into a credible, high-trust environment for international investors.
The 200-Company Milestone: Under her leadership, over 200 Nigerian pharma companies have achieved international standards, turning the nation into a burgeoning pharmaceutical hub for Africa.
Advanced Infrastructure: Nigeria is now home to a state-of-the-art vaccines and biologics laboratory in Lagos, one of the rare facilities of its kind in Sub-Saharan Africa.
A Call to Action for Investors
The NAFDAC boss urged Bangladeshi investors to look beyond the horizon and establish manufacturing plants directly within Nigeria. By tapping into the local market, both nations can ensure the availability of safe, high-quality, and affordable medicines while boosting economic growth.
”Nigeria is open for investment, particularly in vaccine production. Our robust regulatory framework ensures that every medicine in circulation is safe, efficacious, and globally competitive.”
— Prof. Mojisola Adeyeye
How this impacts the “Big Picture”
Lower Costs: Local manufacturing reduces the heavy cost of importing essential drugs.
Job Creation: New facilities mean more high-tech roles for Nigerian professionals.
Health Security: Strengthening local production is the ultimate shield against global supply chain disruptions.